Our results also showed an increased expression of NTRK1 in cisplatin‐resistant NSCLC cells compared to sensitive cells (logFC: 2.00152, p.value: 1.15E‐09). This evidence concerns the gene NTRK1 and non-small cell lung carcinoma.